HOME
SEARCH
RSS FEED
SUBSCRIBE
Stem Cell Factor-responsive FcepsilonRI Bearing Human Mast Cell Line LAD2
Case ID:
TAB-641
Web Published:
12/6/2022
Description:
A human mast cell line LAD2 that more closely resembles normal in vivo and in vitro human mast cells by expressing functional FcepsilonRI receptors and responding to stem cell factor (SCF) with proliferation, as described in Leuk Res. 2003 Aug;27(8):677-82 and developed by the laboratory of Dr. Dean Metcalfe at the National Institute of Allergy and Infectious Diseases. This cell line also releases mediators by cross-linking FcgammaRI (CD64) receptors and express FcgammaRII (CD32).
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://nih.technologypublisher.com/tech/Stem_Cell_Factor-responsive_Fcepsilo nRI_Bearing_Human_Mast_Cell_Line_LAD2
Category(s):
Licensing
Research Materials
Diagnostics
Therapeutics
Immunology
Bookmark this page
Download as PDF
For Information, Contact:
Daniel Lee
Senior Licensing and Patenting Manager
NIH Technology Transfer
daniel.lee5@nih.gov
Inventors:
Arnold Kirshenbaum
Cem Akin
Dean Metcalfe
Keywords:
Cell line
IA3XXX
IAXXXX
IDXXXX
IXXXXX
Mast cell disease
Mastocytosis
RM
WIXXXX
Home
|
Search
|
RSS
|
Subscribe
© 2025. All Rights Reserved. Powered by
Inteum